Почетна › ХОБП › Северна Каролина
Kliničke studije za ХОБП u državi Северна Каролина
24 studija za ХОБП traži učesnike na lokacijama u državi Северна Каролина.
Gradovi u državi Северна Каролина
Zvanični tekst studije (na engleskom)
A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis
- Copd01 50017, Charlotte
Тражи се учесникФаза 2
Узраст од 40 до 80 · Оба пола · Ажурирано 6. 11. 2026. · NCT07725939Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
- Wake Forest School of Medicine, Salem
Тражи се учесник
Узраст од 40 до 80 · Оба пола · Ажурирано 5. 11. 2026. · NCT07051707WIN Ratio Analysis to Determine a Strategy of Non- Invasive SUpport for Respiratory Failure in the EmeRgency Department
- Wake Forest Baptist Medical Center, Winston-Salem
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07558265To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- Eximia Research, Raleigh
- Carolina Research Center, Inc., Shelby
Тражи се учесникФаза 2
Узраст од 40 до 85 · Оба пола · Ажурирано 28. 10. 2026. · NCT07684820A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, New Bern
Тражи се учесникФаза 2
Узраст 40 и старији · Оба пола · Ажурирано 23. 10. 2026. · NCT07082738Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- East Carolina University- Site Number : 8400102, Greenville
- All-Trials Clinical Research- Site Number : 8400008, Winston-Salem
Тражи се учесникФаза 3
Узраст од 40 до 80 · Оба пола · Ажурирано 23. 10. 2026. · NCT07190222A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
- WB Contracted Clinical Research Site, Charlotte
Тражи се учесникФаза 2
Узраст од 40 до 80 · Оба пола · Ажурирано 23. 10. 2026. · NCT07646587A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Salem Chest Specialists, Winston-Salem
- Southeastern Research Center, Winston-Salem
Тражи се учесникФаза 2/3
Узраст од 35 до 80 · Оба пола · Ажурирано 22. 10. 2026. · NCT07363694A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
- American Health Research - Charlotte- Site Number : 8400013, Charlotte
- Atrium Health Wake Forest Baptist Pulmonary, Sleep And Allergy- Site Number : 8400004, Winston-Salem
Тражи се учесникФаза 4
Узраст од 40 до 85 · Оба пола · Ажурирано 20. 10. 2026. · NCT07053423Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Duke Asthma, Allergy and Airway Center- Site Number : 8400047, Durham
- Advanced Respiratory and Sleep Medicine - Hickory- Site Number : 8400013, Hickory
- Science 37, Llc- Site Number : 8400154, Morrisville
- и још 1
Тражи се учесникФаза 3
Узраст од 40 до 80 · Оба пола · Ажурирано 19. 10. 2026. · NCT07190209STRIVE Post-Market Registry Study
- Duke University Medical Center, Durham
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 16. 10. 2026. · NCT04302272The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry
- Duke, Durham
Тражи се учесникОпсервациона студија
Узраст 40 и старији · Оба пола · Ажурирано 15. 10. 2026. · NCT07612878A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Charlotte
- Research Site, Concord
Тражи се учесникФаза 3
Узраст од 40 до 80 · Оба пола · Ажурирано 9. 10. 2026. · NCT06878261Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Shelby
Тражи се учесникФаза 3
Узраст од 40 до 80 · Оба пола · Ажурирано 5. 10. 2026. · NCT06961214Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
- GSK Investigational Site, Winston-Salem
- GSK Investigational Site, Winston-Salem
Тражи се учесникФаза 3
Узраст од 40 до 80 · Оба пола · Ажурирано 5. 10. 2026. · NCT06959095A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Greensboro
- Research Site, Greenville
- Research Site, Huntersville
- и још 3
Тражи се учесникФаза 3
Узраст од 40 до 80 · Оба пола · Ажурирано 2. 10. 2026. · NCT06283966Nebulizer Versus Handheld Maintenance Therapy for Patients With COPD
- Southeastern Research Center, Winston-Salem
Тражи се учесникФаза 4
Узраст 60 и старији · Оба пола · Ажурирано 14. 9. 2026. · NCT07816835A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, High Point
- Research Site, Kings Mountain
- Research Site, New Bern
- и још 1
Тражи се учесникФаза 3
Узраст од 40 до 80 · Оба пола · Ажурирано 3. 9. 2026. · NCT06883305Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With Hypoxemia
- Duke Asthma Allergy and Airway Center, Durham
Тражи се учесникФаза 2
Узраст 40 и старији · Оба пола · Ажурирано 27. 8. 2026. · NCT07037836Photon-counting CT in Chest Imaging
- Duke University Hospital, Durham
Тражи се учесник
Сви узрасти · Оба пола · Ажурирано 26. 8. 2026. · NCT07031336eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Winston-Salem
Тражи се учесникФаза 3
Узраст од 40 до 75 · Оба пола · Ажурирано 28. 7. 2026. · NCT07177339SPIROMICS Study of Early COPD Progression (SOURCE)
- Wake Forest, Winston-Salem
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 30 до 55 · Оба пола · Ажурирано 3. 6. 2026. · NCT05033990Pulmonary Hypertension SOLAR
- Duke University Medical Center, Durham
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 24. 2. 2026. · NCT04778046Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Wakemed, Raleigh
Тражи се учесникОпсервациона студија
Узраст 50 и старији · Оба пола · Ажурирано 5. 8. 2025. · NCT06122077Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.